Transcatheter Arterial Chemoembolization Combined with Percutaneous Injection of Ethnol for Treatment of Hepatocellularcarcinoma: In Comparison to Transcatheter Arterial Chemoemboliztion Treated Hepatic Cellular Carcinoma

Background: Hepatic cellular carcinoma (HCC) is one f the leading cause of death. The objective of study is to see the better treatment option by comparing treatment outcome of two groups, one group given combination therapy of TACE and TEI and other treated by TACE alone. Method(s): A total of 60 patients (51 men and 9 women; age ranging from 48- 80 years) with histopathologically proven HCC were consecutively enrolled from 2016 to 2017 from data base of shifa international hospital. Thirty patient with combination of TACE with PEI (the combo group) and thirty with TACE alone (the control group). Treatment response based on size and enhancement pattern of the lesion were evaluated on serial CT. Result(s): 36% patient from combination group show full response, 43% partial response and 20% worsened response. 13% patient from TACE only treated group showed full response, 56% partial response and 30% worsened response. Conclusion(s): The study shows that the response of hepatocellular carcinoma (HCC) to combination of trans catheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) is better in comparison to those treated with trans catheter arterial chemoembolization (TACE) alone.

Publikationsverlauf

Artikel online veröffentlicht:
11. Mai 2021